AWM Investment Company, Inc.

This profile gathers the share dealings of AWM Investment Company, Inc. across 24 companies, led by Intellicheck, Inc., Genasys Inc. and Ernexa Therapeutics Inc. In total, 229 filings cover trades dated from 30 December 2015 to 29 September 2026.

On the open market, the record shows 9 purchases worth €4.8M and 220 sales worth €24.4M. Sales outweigh purchases by €19.7M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2026, the count stands at no purchases and 13 sales.

A typical purchase (the median) is worth €52k. Clusters matter here: 2 out of 8 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster. For 4 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 75% of cases, with a median move of +1.7%. Past outcomes like these are no guarantee of what comes next.

The latest filing, published on 1 October 2026, reports an open-market sale of €182k in 908 Devices Inc. The clock since the last published purchase (2 October 2023) now reads 1,115 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.